A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
Hoffmann-La Roche
University of California, San Diego
National Cancer Institute (NCI)
University of Kentucky
University of California, San Diego
Hoffmann-La Roche
Numab Therapeutics AG
Regeneron Pharmaceuticals
Intensity Therapeutics, Inc.
University of Utah
Atara Biotherapeutics
University of California, San Francisco
Amgen
The University of Texas Health Science Center at San Antonio
University of Chicago
Eli Lilly and Company
Eli Lilly and Company
University of Pittsburgh
Dana-Farber Cancer Institute
University of Chicago
Sanofi
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Memorial Sloan Kettering Cancer Center
Pfizer
AstraZeneca